| 1 |
Bulvik BE， Rozenblum N， Gourevich S， et al.Irreversible electroporation versus radiofrequency ablation： a comparison of local and systemic effects in a small-animal model［J］.Radiology， 2016，280（2）： 413-424.
|
| 2 |
Narayanan JSS， Ray P， Hayashi T， et al.Irreversible electroporation combined with checkpoint blockade and TLR7 stimulation induces antitumor immunity in a murine pancreatic cancer model［J］.Cancer Immunol Res， 2019， 7（10）： 1714-1726.
|
| 3 |
He C， Huang X， Zhang Y， et al.T-cell activation and immune memory enhancement induced by irreversible electroporation in pancreatic cancer［J］.Clin Transl Med， 2020， 10（2）： e39.
|
| 4 |
Vallin JR， Azarin SM.Leveraging the immunological impacts of irreversible electroporation as a new frontier for cancer therapy［J］.Annu Rev Chem Biomol Eng， 2025 （ahead of print）.
|
| 5 |
Justesen TF， Orhan A， Raskov H， et al.Electroporation and immunotherapy-unleashing the abscopal effect［J］.Cancers （Basel），2022， 14（12）： 2876.
|
| 6 |
Walsh MP， Duncan B， Larabee S， et al.Val-BoroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors［J］.PLoS One， 2013，8（4）： e58860.
|
| 7 |
Man SM， Karki R， Kanneganti TD.Molecular mechanisms and functions of pyroptosis， inflammatory caspases and inflammasomes in infectious diseases［J］.Immunol Rev， 2017， 277（1）： 61-75.
|
| 8 |
Tang R， Zhang Z， Liu X， et al.Stromal stiffness-regulated IGF2BP2 in pancreatic cancer drives immune evasion via sphingomyelin metabolism［J］.Gastroenterology， 2025 （ahead of print）.
|
| 9 |
Jenkins EPW， Finch A， Gerigk M， et al.Electrotherapies for glioblastoma［J］.Adv Sci （Weinh）， 2021， 8（18）： e2100978.
|
| 10 |
Geboers B， Scheffer HJ， Graybill PM， et al.High-voltage electrical pulses in oncology： irreversible electroporation， electrochemotherapy，gene electrotransfer， electrofusion， and electroimmunotherapy［J］.Radiology， 2020， 295（2）： 254-272.
|
| 11 |
Ngwa W， Irabor OC， Schoenfeld JD， et al.Using immunotherapy to boost the abscopal effect［J］.Nat Rev Cancer， 2018， 18（5）： 313-322.
|
| 12 |
Zhao J， Wen X， Tian L， et al.Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer［J］.Nat Commun， 2019， 10（1）： 899.
|
| 13 |
Ngwa W， Irabor OC， Schoenfeld JD， et al.Using immunotherapy to boost the abscopal effect［J］.Nat Rev Cancer， 2018， 18（5）： 313-322.
|
| 14 |
Mariathasan S， Turley SJ， Nickles D， et al.TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells［J］.Nature， 2018， 554（7693）： 544-548.
|
| 15 |
Frydrychowicz M， Boruczkowski M， Kolecka-Bednarczyk A， et al.The dual role of Treg in cancer［J］.Scand J Immunol， 2017， 86（6）： 436-443.
|
| 16 |
Stamatovic SM， Keep RF， Mostarica-Stojkovic M， et al.CCL2 regulates angiogenesis via activation of Ets-1 transcription factor［J］.J Immunol， 2006， 177（4）： 2651-2661.
|
| 17 |
Imran KM， Nagai-Singer MA， Brock RM， et al.Exploration of novel pathways underlying irreversible electroporation induced anti-tumor immunity in pancreatic cancer［J］.Front Oncol， 2022， 12： 853779.
|
| 18 |
Kalbasi A， Ribas A.Tumour-intrinsic resistance to immune checkpoint blockade［J］.Nat Rev Immunol， 2020， 20（1）： 25-39.
|
| 19 |
Babikr F， Wan J， Xu A， et al.Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors［J］.Cell Mol Immunol， 2021， 18（12）： 2632-2647.
|
| 20 |
Vivas I， Iribarren K， Lozano T， et al.Therapeutic effect of irreversible electroporation in combination with poly-ICLC adjuvant in preclinical models of hepatocellular carcinoma［J］.J Vasc Interv Radiol， 2019，30（7）： 1098-1105.
|
| 21 |
Narayanan JSS， Ray P， Hayashi T， et al.Irreversible electroporation combined with checkpoint blockade and TLR7 stimulation induces antitumor immunity in a murine pancreatic cancer model［J］.Cancer Immunol Res， 2019， 7（10）： 1714-1726.
|
| 22 |
Zhou W， Yu M， Mao X， et al.Landscape of the peripheral immune response induced by local microwave ablation in patients with breast cancer［J］.Adv Sci （Weinh）， 2022， 9（17）： e2200033.
|
| 23 |
Lin M， Alnaggar M， Liang S， et al.An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer［J］.Oncotarget， 2017， 8（60）： 101795-101807.
|
| 24 |
Han JH， Lee YY， Shin HE， et al.Image-guided in situ cancer vaccination with combination of multi-functional nano-adjuvant and an irreversible electroporation technique［J］.Biomaterials， 2022， 289：121762.
|
| 25 |
Polajžer T， Miklavčič D.Immunogenic cell death in electroporationbased therapies depends on pulse waveform characteristics［J］.Vaccines （Basel）， 2023， 11（6）： 1036.
|
| 26 |
Woeste MR， Shrestha R， Geller AE， et al.Irreversible electroporation augments β-glucan induced trained innate immunity for the treatment of pancreatic ductal adenocarcinoma［J］.J Immunother Cancer， 2023，11（4）： e006221.
|
| 27 |
Martin RC， Li Y， Shore EA， et al.Irreversible electroporation and betaglucan-induced trained innate immunity for treatment of pancreatic ductal adenocarcinoma： a phase II study［J］.J Am Coll Surg， 2025，240（4）： 351-361.
|
| 28 |
Long X， Dai A， Huang T， et al.Simultaneous delivery of dual inhibitors of DNA damage repair sensitizes pancreatic cancer response to irreversible electroporation［J］.ACS Nano， 2023， 17（13）： 12915-12932.
|
| 29 |
Geboers B， Timmer F， Vos D， et al.Systemic immunomodulation by irreversible electroporation versus stereotactic ablative body radiotherapy in locally advanced pancreatic cancer： the CROSSFIRE trial［J］.J Immunother Cancer， 2025， 13（3）： e010222.
|
| 30 |
Ma Y， Xing Y， Li H， et al.Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer［J］.Front Immunol，2023， 14： 1193040.
|
| 31 |
Huang T， Wen X， Liang Y， et al.Irreversible electroporation-induced inflammation facilitates neutrophil-mediated drug delivery to enhance pancreatic cancer therapy［J］.Mol Pharm， 2024， 21（4）： 1998-2011.
|
| 32 |
Imran KM， Brock RM， Beitel-White N， et al.Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model［J］.Front Immunol， 2024， 15： 1352821.
|
| 33 |
Zeng C， Hua S， Zhou J， et al.Oral microalgae-based biosystem to enhance irreversible electroporation immunotherapy in hepatocellular carcinoma［J］.Adv Sci （Weinh）， 2025， （ahead of print）.
|
| 34 |
Liu X， Zhuang Y， Huang W， et al.Interventional hydrogel microsphere vaccine as an immune amplifier for activated antitumour immunity after ablation therapy［J］.Nat Commun， 2023， 14（1）： 4106.
|
| 35 |
Peng W， Cao Y， Zhang Y， et al.Optimal irreversible electroporation combined with nano-enabled immunomodulatory to boost systemic antitumor immunity［J］.Adv Healthc Mater， 2024， 13（7）： e2302549.
|
| 36 |
Li Y， Lam SSK， Gao Y， et al.Enhancing the immunotherapeutic effect by IP-001 and irreversible electroporation in mouse oligometastatic models of pancreatic adenocarcinoma［J］.Ann Surg Oncol， 2025，32（4）： 2786-2798.
|
| 37 |
Karwacki J， Kiełbik A， Szlasa W， et al.Boosting the immune response—combining local and immune therapy for prostate cancer treatment［J］.Cells， 2022， 11（18）： 2793.
|
| 38 |
Ma YY， Wang XH， Zeng JY， et al.Irreversible electroporation combined with anti-programmed cell death protein 1 therapy promotes tumor antigen-specific CD8+ T cell response［J］.World J Gastrointest Oncol， 2025， 17（3）： 101991.
|